Complete loss of ischaemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF-1α

Cardiovascular Research

Volumn 77, Issue 3, 2008, Pages 463-470

  Cai, Zheqing ^a   Zhong, Hua ^a   Bosch Marce, Marta ^a   Fox Talbot, Karen ^a   Wang, Lei ^a   Wei, Chiming ^a   Trush, Michael A ^b   Semenza, Gregg L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b The Johns Hopkins University   (United States)

Author keywords

Hypoxia; Myocardial infarction; Reactive oxygen species

Indexed keywords

ADENOSINE; CASPASE 3; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; TRIPHENYLTETRAZOLIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD FLOW VELOCITY; CHEMOLUMINESCENCE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; ENZYME DEGRADATION; ENZYME PHOSPHORYLATION; EXPERIMENTAL MOUSE; GENE LOCUS; HEART INFARCTION SIZE; HEART LEFT VENTRICLE PRESSURE; HEART MITOCHONDRION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART RATE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; ISCHEMIC PRECONDITIONING; MALE; MOUSE; NEWBORN; NICK END LABELING; NONHUMAN; NULL ALLELE; OXIDATION; PRIORITY JOURNAL; PROTEIN DEFICIENCY; WILD TYPE;

ADENOSINE; ANIMALS; APOPTOSIS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MICE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; REACTIVE OXYGEN SPECIES;

EID: 38849182762     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvm035     Document Type: Article

References (54)

1. Fliss H, Gattinger D. Apoptosis in ischemic and reperfused rat myocardium. Circ Res 1996;79:949-956.
2. Murphy E. Primary and secondary signaling pathways in early preconditioning that converge on the mitochondria to produce cardioprotection. Circ Res 2003;94:7-16.
3. Dirksen MT, Laarman GJ, Simoons ML, Duncker JGM. Reperfusion injury in humans: a review of clinical trials on reperfusion injury inhibitory strategies. Cardiovasc Res 2007;74:343-355.
4. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-1136.
5. Halestrap AP, Clarke SJ, Khaliulin I. The role of mitochondria in protection of the heart by preconditioning. Biochim Biophys Acta 2007;1767:1007-1031.
6. Tanaka M, Fujiwara H, Yamasaki K, Sasayama S. Superoxide dismutase and N-2-mercaptopropionyl glycine attenuate infarct size limitation effect of ischaemic preconditioning in the rabbit. Cardiovasc Res 1994;28:980-986.
7. Baines CP, Goto M, Downey JM. Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J Mol Cell Cardiol 1997;29:207-216.
8. Tritto I, D'Andrea D, Eramo N, Scognamiglio A, De Simone C, Violante A et al. Oxygen radicals can induce preconditioning in rabbit hearts. Circ Res 1997;80:743-748.
9. Chen W, Gabel S, Steenbergen C, Murphy E. A redox-based mechanism for cardioprotection induced by ischemic preconditioning in perfused rat heart. Circ Res 1995;77:424-429.
10. Das DK, Maulik N, Sato M, Ray PS. Reactive oxygen species function as second messenger during ischemic preconditioning of heart. Mol Cell Biochem 1999;196:59-67.
11. Forbes RA, Steenbergen C, Murphy E. Diazoxide-induced cardioprotection requires signaling through a redox-sensitive mechanism. Circ Res 2001;88:802-809.
12. Vanden Hoek TL, Becker LB, Shao Z, Li C, Schumacker PT. Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes. J Biol Chem 1998;273:18092-18098.
13. Bell RM, Cave AC, Johar S, Hearse DJ, Shah AM, Shattock MJ. Pivotal role of NOX-2-containing NADPH oxidase in early ischemic preconditioning. FASEB J 2005;19:2037-2039.
14. Speechly-Dick ME, Mocanu MM, Yellon DM. Protein kinase C. Its role in ischemic preconditioning in the rat. Circ Res 1994;75:586-590.
15. 2, a necessary evil for cell signaling. Science 2006;312:1882-1883.
16. 2. J Biol Chem 2000;277:20336-20342.
17. Budas GR, Sukhodub A, Alessi DR, Jovanovic A. 3′-Phosphoinositide- dependent kinase-1 is essential for ischemic preconditioning of the myocardium. FASEB J 2006;20:2556-2558.
18. Cai Z, Semenza GL. PTEN activity is modulated during ischemia and reperfusion: involvement in the induction and decay of preconditioning. Circ Res 2005;97:1351-1359.
19. Mocanu MM, Yellon DM. PTEN, the Achilles' heel of myocardial ischaemia/reperfusion injury? Br J Pharmacol 2007;150:833-838.
20. Hardt SE, Sadoshima J. Glycogen synthase kinase-3β: a novel regulator of cardiac hypertrophy and development. Circ Res 2002;90:1055-1063.
21. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E et al. Regulation of cell death protease caspase-9 by phosphorylation. Science 1998;282:1318-1321.
22. Del Peso L, Gonzalez-Garcia M, Page C, Herrera R, Nunez G. Interleukin-3-induced phosphorylation of BAD through the protein kinase AKT. Science 1997;278:687-689.
23. Uchiyama T, Engelman RM, Maulik N, Das DK. Role of AKT signaling in mitochondrial survival pathway triggered by hypoxic preconditioning. Circulation 2004;109:3042-3049.
24. Ping P, Takano H, Zhang J, Tang XL, Qiu Y, Li RC et al. Isoform-selective activation of protein kinase C by nitric oxide in the heart of conscious rabbits: a signaling mechanism for both nitric oxide-induced and ischemia-induced preconditioning. Circ Res 1999;84:587-604.
25. Baines CP, Song CX, Zheng YT, Wang GW, Zhang J, Wang OL et al. Protein kinase Cε interacts with and inhibits the permeability transition pore in cardiac mitochondria. Circ Res 2003;92:873-880.
26. 2 tension. Proc Natl Acad Sci USA 1995;92:5510-5514.
27. Martin C, Yu AY, Jiang BH, Davis L, Kimberly D, Hohimer AR et al. Cardiac hypertrophy in chronically anemic fetal sheep: increased vascularization is associated with increased myocardial expression of vascular endothelial growth factor and hypoxia-inducible factor 1. Am J Obstet Gynecol 1998;178:527-534.
28. Lee SH, Wolf PL, Escudero R, Deutsch R, Jamieson SW, Thistlethwaite PA. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med 2000;342:626-633.
29. Fandrey J, Gorr TA, Gassmann M. Regulating cellular oxygen sensing by hydroxylation. Cardiovasc Res 2006;71:642-651.
30. 2 homeostasis by hypoxia-inducible factor 1α. Genes Dev 1998;12:149-162.
31. Compernolle V, Brusselmans K, Franco D, Moorman A, Dewerchin M, Collen D et al. Cardia bifida, defective heart development and abnormal neural crest migration in embryos lacking hypoxia-inducible factor-1α. Cardiovasc Res 2003;60:569-579.
32. Yu AY, Shimoda LA, Iyer NV, Huso DL, Sun X, McWilliams R et al. Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α. J Clin Invest 1999;103:691- 696.
33. Semenza GL. Regulation of physiological responses to continuous and intermittent hypoxia by hypoxia-inducible factor 1. Exp Physiol 2006;91:803-806.
34. Li Y, Zhu H, Trush MA. Detection of mitochondria-derived reactive oxygen species production by the chemilumigenic probes lucigenin and luminol. Biochim Biophys Acta 1999;1428:1-12.
35. Cai Z, Manalo DJ, Wei G, Rodriguez ER, Fox-Talbot K, Lu H et al. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation 2003;108:79-85.
36. ATP channels. Circ Res 2002;89:273-278.
37. Chandel NS, Maltepe E, Goldwasser E, Mathieu CE, Simon MC, Schumacker PT. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci USA 1998;95:11715-11720.
38. Peng YJ, Yuan G, Ramakrishnan D, Sharma SD, Bosch-Marce M, Kumar GK et al. Heterozygous HIF-1α deficiency impairs carotid body-mediated systemic responses and reactive oxygen species generation in mice exposed to intermittent hypoxia. J Physiol 2006;577:705-716.
39. -/- mice. Nat Genet 2003;35:331-340.
40. Oktay Y, Dioum E, Matsuzaki S, Ding K, Yan LJ, Haller RG et al. Hypoxia-inducible factor 2α regulates expression of the mitochondrial aconitase chaperone protein frataxin. J Biol Chem 2007;282:11750- 11766.
41. Raval RR, Lau KW, Tran MG, Sowter HM, Mandriota SJ, Li JL et al. Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. Mol Cell Biol 2005; 25:5675-5686.
42. Kim JW, Tchernyshyov I, Semenza GL, Dang CV. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 2006;3:177-185.
43. Fukuda R, Zhang H, Kim JW, Shimoda L, Dang CV, Semenza GL. HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell 2007;129:111-122.
44. Zhang H, Gao P, Fukuda R, Kumar G, Krishnamachary B, Zeller KI et al. HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. Cancer Cell 2007;11:407-420.
45. Kwon J, Lee SR, Yang KS, Ahn Y, Kim YJ, Stadtman ER et al. Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors. Proc Natl Acad Sci USA 2004;101:16419-16424.
46. Seo JH, Ahn Y, Lee SR, Yeo CY, Hur KC. The major target of the endogenously generated reactive oxygen species in response to insulin stimulation is phosphatase and tensin homolog and not phosphoinositide-3 kinase (PI-3 kinase) in the PI-3 kinase/AKT pathway. Mol Biol Cell 2005;16:348-357.
47. Kelly BD, Hackett SF, Hirota K, Oshima Y, Cai Z, Berg-Dixon S et al. Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 2003;93:1074-1081.
48. Patel TH, Kimura H, Weiss CR, Semenza GL, Hofmann LV. Constitutively active HIF-1α improves perfusion and arterial remodeling in an endovascular model of limb ischemia. Cardiovasc Res 2005;68:144- 154.
49. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004;10:858-864.
50. Resar JR, Roguin A, Voner J, Nasir K, Hennebry TA, Miller JM et al. Hypoxia inducible factor 1α polymorphism and coronary collaterals in patients with ischemic heart disease. Chest 2005;128:787-791.
51. Ockaili R, Natarajan R, Salloum F, Fisher BJ, Jones D, Fowler AA III et al. HIF-1 activation attenuates postischemic myocardial injury: role for heme oxygenase-1 in modulating microvascular chemokine generation. Am J Physiol 2005;289:H542-H548.
52. Natarajan R, Salloum FN, Fisher BJ, Kukreja RC, Fowler AA III. Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury. Circ Res 2006;98:133-140.
53. Cummins EP, Berra E, Comerford KM, Ginouves A, Fitzgerald KT, Seeballuck F et al. Prolyl hydroxylase-1 negatively regulates IκB kinase-β, giving insight into hypoxia-induced NF-κB activity. Proc Natl Acad Sci USA 2006;103:18154-18159.
54. Coleman ML, McDonough MA, Hewitson KS, Coles C, Mecinovic J, Edelmann M et al. Asparaginyl hydroxylation of the notch ankyrin repeat domain by factor inhibiting hypoxia inducible factor. J Biol Chem 2007;282:24027-24038.